Appearance and Shape (20°C) | Solid |
---|---|
CAS RN | 52-67-5 |
MDL number | MFCD00064302 |
Molecular weight | 149.21 |
Molecular Formula | C5H11NO2S |
Product code | ICTP0147 |
PubChem Substance ID | 87574400 |
Purity/Analytical Methods | >98.0%(T) |
Reaxys-RN | 1722375 |
SDBS (AIST Spectral DB) | 5422 |
Appearance | White to Almost white powder to crystal |
---|
Pictograms | |
---|---|
Hazard statement | H315 : Causes skin irritation H319 : Causes serious eye irritation. |
Precautionary Statements | P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ eye protection/ face protection P337 + P313 : If eye irritation persists: Get medical advice/ attention P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P302 + P352 : IF ON SKIN: Wash with plenty of soap and water P332 + P313 : If skin irritation occurs: Get medical advice/ attention P362 : Take off contaminated clothing and wash before reuse. |
Signal word | Warning |
RTECS# | YV9425000 |
---|
Chemistry Chemical Biology Peptide Chemistry Penicillamine Derivatives [Unnatural Amino Acid Derivatives] Unnatural Amino Acid Derivatives Pharmaceutical Development and Drug Discovery Research Reagents Peptide Chemistry Penicillamine Derivatives [Unnatural Amino Acid Derivatives] Unnatural Amino Acid Derivatives
Life Science Biochemicals and Reagents Amino Acids non-Proteinogenic Amino Acids Pharmaceutical Ingredients (for Research and Experimental Use) Anti-rheumatoid Arthritis Ingredients (for Research and Experimental Use) Disease Modifying Anti-rheumatics (DMARDs) Immunosuppressant Ingredients (for Research and Experimental Use) Cell Biology Immune System, Inflammation, Allergy Research Immunocomplex Dissociating Agents Pharmaceutical Development and Drug Discovery Research Peptide Chemistry Penicillamine Derivatives [Unnatural Amino Acid Derivatives] Unnatural Amino Acid Derivatives Pharmaceutical Ingredients (for Research and Experimental Use) Anti-rheumatoid Arthritis Ingredients (for Research and Experimental Use) Disease Modifying Anti-rheumatics (DMARDs) Immunosuppressant Ingredients (for Research and Experimental Use)